One expert who studies emerging infectious diseases called Kennedy's past tweets and remarks about the HPV vaccine "complete ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

These beverages, packed with bioactive compounds, bring new hope in the fight against this disease, affecting thousands of ...

“The Tree Man was Dede Koswara, an Indonesian man who suffered from a rare genetic disorder called Epidermodysplasia ...

Chemo mouth is a common side effect of undergoing chemotherapy. Dr. Rajiv Saini of Texas discusses the symptoms, risks and ...

Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...

KOCHI: It’s not just smokers or regular tobacco users that are susceptible to oral cancer. A recent study by the head and ...

The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...